Kamyar Kalantar-Zadeh M.D. to Parathyroid Hormone
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Parathyroid Hormone.
Connection Strength
5.467
-
Racial-ethnic differences in chronic kidney disease-mineral bone disorder in youth on dialysis. Pediatr Nephrol. 2019 01; 34(1):107-115.
Score: 0.593
-
Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis. Perit Dial Int. 2014 Nov-Dec; 34(7):732-48.
Score: 0.427
-
Correlates of parathyroid hormone concentration in hemodialysis patients. Nephrol Dial Transplant. 2013 Jun; 28(6):1516-25.
Score: 0.400
-
Target levels for serum phosphorus and parathyroid hormone. Semin Dial. 2011 Jan-Feb; 24(1):29-33.
Score: 0.350
-
Insights into nutritional and inflammatory aspects of low parathyroid hormone in dialysis patients. J Ren Nutr. 2011 Jan; 21(1):100-4.
Score: 0.347
-
Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients. J Ren Nutr. 2010 Jul; 20(4):243-54.
Score: 0.327
-
Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2008 Nov; 3(6):1769-76.
Score: 0.294
-
Calcium Transport in the Kidney and Disease Processes. Front Endocrinol (Lausanne). 2021; 12:762130.
Score: 0.188
-
Parenteral iron therapy and phosphorus homeostasis: A review. Am J Hematol. 2021 05 01; 96(5):606-616.
Score: 0.175
-
Association of Mineral Bone Disorder With Decline in Residual Kidney Function in Incident Hemodialysis Patients. J Bone Miner Res. 2020 02; 35(2):317-325.
Score: 0.160
-
Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study. BMC Nephrol. 2019 10 29; 20(1):396.
Score: 0.160
-
Seasonal variation of serum 25-hydroxyvitamin D and parameters of bone and mineral disorder in dialysis patients. Bone. 2019 07; 124:158-165.
Score: 0.153
-
The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis. 2018 12; 72(6):834-845.
Score: 0.148
-
Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function. Clin J Am Soc Nephrol. 2017 Jul 07; 12(7):1118-1127.
Score: 0.135
-
Development and Validation of a Novel Laboratory-Specific Correction Equation for Total Serum Calcium and Its Association With Mortality Among Hemodialysis Patients. J Bone Miner Res. 2017 Mar; 32(3):549-559.
Score: 0.130
-
Successful Conversion From Parenteral Paricalcitol to Pulse Oral Calcitriol for the Management of Secondary Hyperparathyroidism in Hemodialysis Patients. J Ren Nutr. 2016 07; 26(4):265-9.
Score: 0.125
-
Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients. Am J Nephrol. 2016; 43(2):85-96.
Score: 0.124
-
Alkaline phosphatase: better than PTH as a marker of cardiovascular and bone disease? Hemodial Int. 2014 Oct; 18(4):720-4.
Score: 0.112
-
Mortality of combined serum phosphorus and parathyroid hormone concentrations and their changes over time in hemodialysis patients. Bone. 2014 Apr; 61:201-7.
Score: 0.107
-
Impact of age on survival predictability of bone turnover markers in hemodialysis patients. Nephrol Dial Transplant. 2013 Oct; 28(10):2535-45.
Score: 0.104
-
Administered paricalcitol dose and survival in hemodialysis patients: a marginal structural model analysis. Pharmacoepidemiol Drug Saf. 2012 Nov; 21(11):1232-9.
Score: 0.098
-
Diuretics and secondary hyperparathyroidism in chronic kidney disease. Nephrol Dial Transplant. 2011 Apr; 26(4):1122-5.
Score: 0.088
-
Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients. Am J Nephrol. 2010; 32(5):403-13.
Score: 0.085
-
Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl. 2010 Aug; (117):S10-21.
Score: 0.084
-
Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients. J Bone Miner Res. 2010 Dec; 25(12):2724-34.
Score: 0.084
-
Cinacalcet lowers serum alkaline phosphatase in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2009 Mar; 4(3):673-9.
Score: 0.076
-
Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol. 2008 Nov; 19(11):2193-203.
Score: 0.073
-
Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int. 2008 Jun; 73(11):1296-302.
Score: 0.071
-
Vitamin D receptor activation and survival in chronic kidney disease. Kidney Int. 2008 Jun; 73(12):1355-63.
Score: 0.071
-
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. 2006 Aug; 70(4):771-80.
Score: 0.063
-
Comparative Effectiveness of Dialysis Modality on Laboratory Parameters of Mineral Metabolism. Am J Nephrol. 2022; 53(2-3):157-168.
Score: 0.047
-
Race and Ethnicity Predict Bone Markers and Fracture in Pediatric Patients With Chronic Kidney Disease. J Bone Miner Res. 2021 02; 36(2):298-304.
Score: 0.043
-
Using a web-based nutrition algorithm in hemodialysis patients. J Ren Nutr. 2015 Jan; 25(1):6-16.
Score: 0.028